MedTrace Logo

Multi-Institutional Registry for Prostate Cancer Radiosurgery

NCT01226004 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2019-08-06

No results posted yet for this study

Summary

To address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including prostate specific antigen (PSA), international prostate symptom score (IPSS),sexual health in men (SHIM), and visual analogue scale (VAS) scores, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries, FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data, requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.

Conditions

  • Prostate Cancer Early Risk Treated by Radiosurgery
  • Prostate Cancer Intermediate Risk Treated by Radiosurgery

Sponsors & Collaborators

  • RPCR, Inc.

    lead OTHER

Principal Investigators

  • Mark L. Perman, MD · South Florida Radiation Oncology, LLC.

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01226004 on ClinicalTrials.gov